pre-seed
Stage
1
Investors
About
GlygenIQ is a biotechnology company developing novel therapeutic approaches to treat neurodegenerative diseases. They focus on targeting the glymphatic system to restore its function and improve brain health.
Explore GlygenIQ's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.